Polymorphisms in some proinflammatory genes (TNFα and β, IL-1β, IL-6, ADAM17) in severe chronic venous disease by V Slonková

CONCLUSION: Studying of these polymorphisms associations can help us better identify patients at higher risk of developing severe CVD.

J Eur Acad Dermatol Venereol. 2022 Nov 24. doi: 10.1111/jdv.18770. Online ahead of print.

ABSTRACT

BACKGROUND: Chronic venous disease (CVD) is a common disorder of lower extremities.

OBJECTIVES: The study was scheduled to investigate the relationship between polymorphisms in major proinflammatory genes TNF α (-238 A/G; -308 A/G), TNF β (NcoI), IL-1β (+3953 T/C); IL-6 (-174 G/C; -596 G/C) and ADAM17 (3´TACE) and CVD risk. Genotype-phenotype study was calculated to test possible association between examined genotypes and phenotypes of CVD.

METHODS: Finally, 150 CVD patients as well as 227 control subjects were enrolled to the study. Genotypes in proinflammatory gene polymorphisms were identified from isolated DNA by PCR method and restriction analysis.

RESULTS: Significant differences in genotype distribution/allelic frequencies in TNF β gene, IL-1 β gene and in ADAM17 gene polymorphisms were found between CVD women and control ones. In the genotype-phenotype study, identified genotypes were associated with arterial hypertension (ADAM17, IL-6 -men), ischemic heart disease (TNF α and β genes), diabetes mellitus (ADAM17-women, TNF β-men), age of CVD onset (TNF α and IL-6), ulceration (ADAM17), duration of ulceration (ADAM17), ulceration recurrence (ADAM17-women), home care necessity (TNF α), varices surgery (TNF α), erysipelas development (ADAM17 – men) and tumour development (TNF α).

CONCLUSION: Studying of these polymorphisms associations can help us better identify patients at higher risk of developing severe CVD.

PMID:36420762 | DOI:10.1111/jdv.18770

Read More